2022
DOI: 10.1093/schizbullopen/sgac040
|View full text |Cite
|
Sign up to set email alerts
|

The Relationship Between Grey Matter Volume and Clinical and Functional Outcomes in People at Clinical High Risk for Psychosis

Abstract: Objective To examine the association between baseline alterations in grey matter volume (GMV) and clinical and functional outcomes in people at clinical high risk (CHR) for psychosis. Methods 265 CHR individuals and 92 healthy controls were recruited as part of a prospective multi-centre study. After a baseline assessment using magnetic resonance imaging (MRI), participants were followed for at least two years to determine cl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 64 publications
1
0
0
Order By: Relevance
“…Recruitment rates and low level of dropouts indicate that implementing IPS within OASIS is feasible. Although several participants were in some form of employment at baseline, the level of functioning was low as measured by the SOFAS and GAF, and comparable to other similar samples (Mongan et al, 2021; Tognin et al, 2022). In addition, the participant’s level of functioning and clinical symptoms at baseline, and the relatively high (Salazar de Pablo et al, 2021) 6-month transition to psychosis rate (12.9%) at follow-up, demonstrated the feasibility of real-life clinical setting implementation.…”
Section: Discussionsupporting
confidence: 66%
“…Recruitment rates and low level of dropouts indicate that implementing IPS within OASIS is feasible. Although several participants were in some form of employment at baseline, the level of functioning was low as measured by the SOFAS and GAF, and comparable to other similar samples (Mongan et al, 2021; Tognin et al, 2022). In addition, the participant’s level of functioning and clinical symptoms at baseline, and the relatively high (Salazar de Pablo et al, 2021) 6-month transition to psychosis rate (12.9%) at follow-up, demonstrated the feasibility of real-life clinical setting implementation.…”
Section: Discussionsupporting
confidence: 66%